Treating Diabetes Utilizing a Low Carbohydrate Ketogenic Diet and Intermittent Fasting Without Significant Weight Loss: A Case Report.

A1C diabetes fasting insulin resistance ketogenic low carbohydrate nutrition

Journal

Frontiers in nutrition
ISSN: 2296-861X
Titre abrégé: Front Nutr
Pays: Switzerland
ID NLM: 101642264

Informations de publication

Date de publication:
2021
Historique:
received: 28 03 2021
accepted: 04 06 2021
entrez: 15 7 2021
pubmed: 16 7 2021
medline: 16 7 2021
Statut: epublish

Résumé

Prediabetes and diabetes are leading causes of morbidity and mortality in the United States and are growing in prevalence up to 45% of the population over the past 50 years. Current guidelines from the ADA recommend focusing on energy balance, portion sizes, and weight loss while cautioning that no ideal macronutrient composition has been determined. The guidelines also do not recommend intermittent fasting. In contrast, we report three cases of a substantial reduction in A1C without clinically significant weight loss using a unique, patient-centered program that utilizes low carbohydrate diets with intermittent fasting. These results call into question the role of weight reduction in the management of diabetes while highlighting the unique importance of carbohydrate restriction and intermittent fasting. In this study, we demonstrate a case series of three patients with a substantial reduction in A1C and significantly reducing the need for pharmacotherapy without clinically significant weight loss. Although anecdotal, these results call into question the emphasis of ADA on weight reduction and energy intake reduction for the management of diabetes.

Identifiants

pubmed: 34262925
doi: 10.3389/fnut.2021.687081
pmc: PMC8273233
doi:

Types de publication

Case Reports

Langues

eng

Pagination

687081

Informations de copyright

Copyright © 2021 Gavidia and Kalayjian.

Déclaration de conflit d'intérêts

TK discloses spousal ownership of Rosette's Mix, a low-carb baking mix company, and participation in the not-for-profit LowCarbMD podcast. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Curr Opin Endocrinol Diabetes Obes. 2020 Oct;27(5):308-311
pubmed: 32740049
Br J Sports Med. 2018 Jul;52(13):869-871
pubmed: 29439006
Perspect Biol Med. 2006 Winter;49(1):77-83
pubmed: 16489278
Diabetes Care. 2020 Apr;43(4):894-902
pubmed: 32054721
JCI Insight. 2019 Jun 20;4(12):
pubmed: 31217353
Diabetes Care. 2019 May;42(5):731-754
pubmed: 31000505
Diabetes Care. 2020 Jan;43(Suppl 1):S89-S97
pubmed: 31862751
Front Endocrinol (Lausanne). 2019 Jun 05;10:348
pubmed: 31231311
J Eat Disord. 2020 Jan 29;8:2
pubmed: 32010444
BMJ Case Rep. 2020 Jul 7;13(7):
pubmed: 32641437
Arch Intern Med. 2006 Feb 13;166(3):285-93
pubmed: 16476868

Auteurs

Kristen Gavidia (K)

Touro College of Osteopathic Medicine, New York, NY, United States.

Tro Kalayjian (T)

Yale New Haven Health System, New Haven, CT, United States.

Classifications MeSH